Increasing uptake of structured self-management education programmes for type 2 diabetes in a primary care setting: a feasibility study by Huddlestone, Lisa Jane
This is a repository copy of Increasing uptake of structured self-management education 
programmes for type 2 diabetes in a primary care setting: a feasibility study.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/161277/
Version: Published Version
Article:
Huddlestone, Lisa Jane orcid.org/0000-0002-8054-4475 (2020) Increasing uptake of 
structured self-management education programmes for type 2 diabetes in a primary care 
setting: a feasibility study. Pilot and Feasibility Studies. pp. 1-19. ISSN 2055-5784 
https://doi.org/10.1186/s40814-020-00606-0
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
RESEARCH Open Access
Increasing uptake of structured self-
management education programmes for
type 2 diabetes in a primary care setting: a
feasibility study
Melanie Davies1*, Caroline A. Kristunas1,2 , Lisa Huddlestone2, Abualbishr Alshreef3, Danielle Bodicoat1,
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Abstract
Background: Structured self-management education (SSME) for people with type 2 diabetes mellitus (T2DM)
improves biomedical and psychological outcomes, whilst being cost-effective. Yet uptake in the UK remains low. An
‘Embedding Package’ addressing barriers and enablers to uptake at patient, health care professional and organisational
levels has been developed. The aim of this study was to test the feasibility of conducting a subsequent randomised
controlled trial (RCT) to evaluate the Embedding Package in primary care, using a mixed methods approach.
Methods: A concurrent mixed methods approach was adopted. Six general practices in the UK were recruited and
received the intervention (the Embedding Package). Pseudonymised demographic, biomedical and SSME data were
extracted from primary care medical records for patients recorded as having a diagnosis of T2DM. Descriptive statistics
assessed quantitative data completeness and accuracy. Quantitative data were supplemented and validated by a
patient questionnaire, for which two recruitment methods were trialled. Where consent was given, the questionnaire
and primary care data were linked and compared. The cost of the intervention was estimated. An integrated qualitative
study comprising ethnography and stakeholder and patient interviews explored the process of implementation,
sustainability of change and ‘fit’ of the intervention. Qualitative data were analysed using a thematic framework guided
by the Normalisation Process Theory (NPT).
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Results: Primary care data were extracted for 2877 patients. The primary outcome for the RCT, HbA1c, was over 90%
complete. Questionnaires were received from 423 (14.7%) participants, with postal invitations yielding more
participants than general practitioner (GP) prompts. Ninety-one percent of questionnaire participants consented to
data linkage. The mean cost per patient for the Embedding Package was £8.94, over a median follow-up of 162.5 days.
Removing the development cost, this reduces to £5.47 per patient. Adoption of ethnographic and interview methods
in the collection of data was appropriate, and the use of NPT, whilst challenging, enhanced the understanding of the
implementation process. The need to delay the collection of patient interview data to enable the intervention to
inform patient care was highlighted.
Conclusions: It is feasible to collect data with reasonable completeness and accuracy for the subsequent RCT, although
refinement to improve the quality of the data collected will be undertaken. Based on resource use data collected, it was
feasible to produce cost estimates for each individual component of the Embedding Package. The methods chosen to
generate, collect and analyse qualitative data were satisfactory, keeping participant burden low and providing insight into
potential refinements of the Embedding Package and customisation of the methods for the RCT.
Trial registration: ISRCTN, ISRCTN21321635, Registered 07/07/2017—retrospectively registered.
Keywords: Type 2 diabetes, Structured self-management education, Feasibility study
Key messages regarding feasibility
 The feasibility of data collection procedures and
utility of the chosen theoretical framework were
uncertain.
 The study identified that it was feasible to collect
quantitative data with reasonable completeness and
accuracy directly from primary care. The collection
of qualitative data was also found to be feasible, and
the appropriateness of the selected theoretical
framework was confirmed.
 Feasibility and potential benefits of the intervention
were indicated. Refinement of quantitative data
collection methods was recommended to enhance
quality. Further development of the Embedding
Package was highlighted to improve clinician
engagement.
Background
Type 2 diabetes mellitus (T2DM) is a progressive
chronic disease which can lead to a reduced quality of
life and increased prevalence of long-term health com-
plications. Diabetes affects almost 3.7 million people in
the UK [1], a figure that continues to rise [2] despite ef-
forts to promote healthier lifestyle changes and develop-
ments in pharmacological interventions. It is predicted
that by 2035, diabetes will account for 17% of the
National Health Service (NHS) expenditure [3].
A substantial body of evidence demonstrates the bene-
fits of structured self-management education (SSME) in
T2DM [4, 5]. Here, the term SSME is used to encompass
any education programme meeting the recommended
National Institute for Health and Care Excellence
(NICE) criteria [6], regardless of the mode of delivery.
SSME has been shown to be both cost-effective [4] and
result in improved biomedical and psychological out-
comes [5, 7, 8]. Improvements have been seen in HbA1c,
lipids, weight and blood pressure, as well as in depres-
sion and quality of life [5, 7, 8]. It is therefore unsurpris-
ing that NICE recommends SSME to be made available
to patients “at and around the time of diagnosis, with
annual reinforcement and review” [9]. However, despite
the demonstrated benefits of SSME and it being made a
national priority by NICE, rates of uptake to SSME for
those with T2DM have remained low. Latest figures
show that although the number of patients with T2DM-
offered SSME has increased substantially in the last 5
years, and as of 2015, this figure was in excess of 90%, in
the same year, less than 10% of those diagnosed with
T2DM were recorded as having attended [10]. A system-
atic review of the reasons why patients referred to dia-
betes education programmes choose not to attend found
two broad categories of non-attenders [11]. The authors
found the first category to comprise patients who were
unable to attend due to social or logistical reasons,
whilst the second category comprised those patients
who chose not to attend or perceived no benefit in doing
so [11]. The review concluded that the referrers had a
responsibility to ensure that “those who are referred are
appropriate, ready and fully informed”, whilst the
courses that they are referred to should be ‘accessible in
time and place wherever possible’ [11].
There is now a burgeoning literature on the ways in
which health care interventions are implemented in a
variety of organisational settings, yet authors have
highlighted the absence of studies which focus on the
longer-term sustainability of such interventions [12–14].
The question of how improvements in health care are
retained and become embedded or ‘routinised’ in every-
day practice remains poorly understood, and is as much
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a matter of networks of influence and knowledge of pri-
orities and incentive frameworks than as of clinical or
cost-effectiveness in themselves [13]. It is important,
therefore, to explore how to ensure that SSME can be-
come part of routine care in the new organisational
structures of the NHS in ways that are feasible for all
stakeholders. This requires a better understanding of the
contextual factors and processes that encourage the
adoption of structured education interventions and what
the barriers might be to longer term sustainable change
and how to overcome these barriers.
To address this need, an intervention to increase uptake
to SSME was developed. In accordance with guidance
from the UK Medical Research Council [15], multiple
phases of work were undertaken using a multiple-method
approach, informed by the Normalisation Process Theory
(NPT) [16]. Three stages of work were undertaken over a
12-month period. The process was iterative, with each
stage informing subsequent stages. Stage one [an evidence
synthesis comprising a review of 23 published articles and
a secondary analysis of five qualitative data sets (n = 74 in-
terviews) concerning referral to and uptake of SSME for
T2DM] intended to understand how and why stake-
holders engage with and participate in SSME for T2DM
and identify barriers and enablers to SSME referral and
uptake. Next, a guided discussion (Stage two) was facili-
tated among the research team, primary care stakeholders
and providers of SSME to understand which characteris-
tics of an SSME programme are prioritised by stake-
holders, as well as the resources required to address
barriers and deliver solutions. Finally, in Stage three, a
purposive sample of 16 individuals with a professional
interest in SSME, management of chronic health condi-
tions, or the implementation and adoption of interven-
tions in primary care were recruited to participate in a
consultation to rank and select the key functions of an
intervention to increase referral to and engagement with
SSME for T2DM.
The Embedding Package
A theory-and-evidence-based intervention (the Embed-
ding Package) was developed to overcome the previously
identified barriers to the uptake of SSME. The Embed-
ding Package incorporates four key components: (1) a
clear marketing strategy for SSME, (2) a user friendly
and effective referral pathway, (3) new/amended profes-
sional roles, including local clinical champions and an
‘Embedder’, and (4) a toolkit of resources, complemen-
ted by a website. In the operation of the intervention,
the Embedder guides practices and SSME providers and
educators through the implementation process. Tailor-
ing of the intervention to the local context is achieved
through a series of meetings between stakeholders and
the Embedder.
The appointment of an ‘Embedder’ was part of the
new/amended professional roles. The role of the Embed-
der is to liaise between all relevant stakeholders to pro-
mote SSME and use of the resources. A local champion,
identified in each CCG, will promote SSME and the Em-
bedding Package at both practice and CCG level.
Promotional resources targeting different stakeholders
will include (a) patient-facing resources such as promo-
tional posters, SSME invitation letters and self-referral
forms; (b) resources for health care professionals including
document templates, guidance on recruiting staff, refer-
ring patients and increasing staff engagement; and (c) re-
sources for education providers and commissioners that
will consist of electronic administration and referral
systems, sample referral pathways and evidence summar-
ies. In addition, the toolkit will also include guidance on
communication strategies, auditing, conducting local
needs assessments, as well as details of how to ensure pa-
tient accessibility and tailoring of SSME courses and
sessions.
The overall aim of the study presented here was to test
feasibility of conducting a large-scale evaluation of the
Embedding Package in primary care using a mixed
methods approach. This was achieved through the fol-
lowing objectives:
Quantitative:
1. To assess the feasibility of two recruitment and
consent approaches
2. To assess the feasibility of extracting demographic
and biomedical data and information on SSME
referral and attendance from primary care medical
records with sufficient accuracy and completeness
for use in an RCT, particularly HbA1c, the primary
outcome for the RCT.
3. To assess patient willingness to provide consent for
accessing and extracting identifiable data from their
medical records
4. To assess the willingness of patients to provide
consent and complete a questionnaire asking for
demographic data and information on the diagnosis
and management of their diabetes, their history of
being invited to or attending SSME and their
preferences around the method of delivery of SSME
5. To assess the feasibility of capturing cost data for
embedding activities at participating practices and
clinical commissioning groups (CCGs)
Qualitative:
1. To assess the feasibility of using ethnographic
methods in a range of primary care settings
2. To identify and collect context-specific data on the
processes of implementation, sustainability of
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change, and the fit of the Embedding Package with
routine practice
3. To evaluate the application of the Normalisation
Process Theory (NPT) as a way of analysing data
and understanding factors contributing to the
embedding of SSME
4. To explore methods for providing formative
feedback to aid in the refinement of the Embedding
Package and development of RCT study procedures
Methods
Study design
The feasibility study involved collecting data from six
general practices and two SSME providers within two
CCGs in the East Midlands, UK, between May and Au-
gust 2017. Figure 1 provides an overview of the quantita-
tive data collection process.
Quantitative demographic and biomedical data and in-
formation relating to SSME referral and attendance and
diabetes diagnosis and management were gathered from
primary care electronic medical records (extracted data),
SSME providers (health economic data) and question-
naires completed by patients with T2DM (self-reported
data). An integrated concurrent ethnographic study was
undertaken, incorporating observations, interviews and
document analysis. The use of qualitative methods en-
abled an understanding of the implementation and adop-
tion of the Embedding Package within the social,
environmental and organisational context and facilitated
theoretical evaluation of intervention components [17]. In
addition, data relating to the cost of implementing the
intervention were obtained from the practice managers
and an appropriate member of staff in the CCG, using a
questionnaire and interview.
Sample
Three groups of participants were included in this
research: general practice staff, patients and staff in orga-
nisations providing SSME. As this was a feasibility study,
there was no formal sample size calculation. The num-
ber of practices was based on a balance between practi-
calities and having sufficient data to assess its quality
and to give adequate variation in urban and rural prac-
tices. It was anticipated that six practices would provide
data extracted from around 4200 patients. This was
based on an average diabetes register size of 700, in-
formed by figures from a Quality and Outcomes Frame-
work report [18]. All eligible patients in these included
Fig. 1 Flow diagram of the quantitative data collection process
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practices were invited to participate in the questionnaire.
It was assumed that 30% of the patients on the dia-
betes register would attend their surgery during the
recruitment window and be given study information
by a health care professional. It was estimated that
there would be a 20% questionnaire return rate for
this group, so this would collect data from 250 pa-
tients. All remaining eligible patients with T2DM
would receive a postal questionnaire; it was estimated
that 10% of these would be returned. This would re-
sult in a total of ~ 540 patient participants returning
a questionnaire with implied consent. This sample
would then be large enough that a sufficient number
of patients would have returned a completed ques-
tionnaire and agreed to data linkage, to allow assess-
ment of the agreement between the two data sources.
For the integrated ethnographic component, a purpos-
ive approach to sampling aimed to achieve a range of
staff and patients, in terms of roles demography and ex-
perience, within the size and time limits of the wider
study. The aim was to recruit between 12 and 15 patient
participants and conduct between six and ten interviews
with participants representing practices and providers.
Participant recruitment continued until data saturation
was reached.
As we did not intend to generate inference from our
qualitative data, there was no optimum number of partici-
pants. Rather, we invited participation from individuals
who could provide the most productive information,
based on a framework of variables [maximum variation
(patients) and key informants (and where appropriate de-
viant cases)], our practical knowledge of the research area,
and existing literature on primary care implementation re-
search. In addition to relying on saturation of data [19],
we were also guided by principles of adequacy, appropri-
ateness and analytical redundancy—in that one or many
more interviews would not have made additional contri-
butions or provide further insight [20].
Eligibility criteria
General practices using either EMIS Web or TPP Sys-
temOne electronic health record systems and located
within the two participating CCGs were invited to
participate in the study. Practices had to be referring pa-
tients with T2DM to an SSME programme and be will-
ing to sign a data sharing and remote data collection
agreement with PRIMIS (a third party company provid-
ing the data extraction service for the study). This
allowed the collection of anonymised patient data, and
where consent had been provided by patients’ identifi-
able data. Since this study did not aim to assess the ef-
fectiveness of the intervention, a comparator was not
required, and all general practices (and patients with
T2DM within them) received the intervention.
Patients from participating practices were eligible to
have their anonymised data extracted if they were aged
18 years or over and coded in their electronic medical
record as diagnosed with T2DM. Patients with a record
of a terminal illness and life expectancy of < 12months,
housebound or in residential care, or with a dissent code
to data sharing as part of a research study, were ex-
cluded. If the above criteria were met, and the patient
was able to provide informed consent and able to speak,
understand, and read English to a sufficient level to par-
ticipate in the study, they were invited to complete a
questionnaire and an additional consent form, allowing
their data extracted by PRIMIS to be linked to their
questionnaire response.
Health care professionals were eligible for inclusion if
they were employed by a participating practice or an or-
ganisation referring to, providing, or commissioning
SSME, and willing and able to provide informed written
or verbal consent.
Patient recruitment and consent
Quantitative study
Participants were recruited in two ways. Firstly, through the
use of a prompt installed on the electronic health record sys-
tem, which notified the clinician during a consultation of a
patient’s potential eligibility for inclusion in the study. This
encouraged the clinician to make the patient aware of the
study and provide them with a participant information pack
and a copy of the data collection questionnaire for self-
completion. The second method involved postal invitations
to participate. All potentially eligible patients who had not
been invited in person received an information pack and
self-completion questionnaire. Informed consent was implied
by the return of a completed questionnaire directly to the
study team using a pre-paid, self-addressed envelope.
The questionnaire could be completed anonymously as
questions asking for sex, year of birth and ethnicity were
optional. For patients opting to share and link their health
record data to their questionnaire responses, additional
written informed consent was sought and obtained.
Concurrent qualitative studies
Informed written consent was obtained from all partici-
pants undertaking interviews. Informed verbal consent
was sought and obtained prior to and during all observa-
tions. No incentives or disbursements were provided to
participants.
Data collection
Quantitative data collection
Pseudonymised patient data were extracted from pri-
mary care medical records for eligible patients by a third
party (PRIMIS). Data were extracted from each practice
at a single time point in September or October 2017.
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Data extraction procedures were based on those used by
a similar study [21] and extracted data recorded over the
previous 12 months. Information was extracted on age,
sex, ethnicity, date of T2DM diagnosis, HbA1c (mmol/
mol), body mass index (BMI), weight, lipids (total and
HDL), blood pressure (SBP and DBP), medications, atrial
fibrillation, smoking status, hospital admissions and car-
diovascular risk (QRisk2) score. The last value recorded
within the last 12 months was extracted for all biomed-
ical/anthropometric data. Any Read coded data relating
to offering, referring, uptake or did not attend (DNA) of
SSME at any time since diagnosis, with dates, whether
the patient had been approached to take part in the
questionnaire, and whether they declined participation
in the questionnaire study was also collected.
The questionnaire gathered data on registered practice,
diagnosis and management of diabetes (time since T2DM
diagnosis, HbA1c and diabetes medication), history of be-
ing invited to SSME and of attendance at SSME, including
delivery method. The questionnaire also asked for patient
preferences around the delivery of SSME, i.e. web-based
or face-to-face. Basic demographic information was also
sought on year of birth, sex and ethnicity; however, re-
sponses to these items were optional.
Qualitative data collection
Traditional ethnographic methods were used to collect
data (key-informant and semi-structured interviews, nat-
uralistic observation and collection of relevant docu-
ments and publically available information). The aim
was to identify methodological barriers and facilitators,
develop feedback processes between the qualitative and
wider study team, provide insight into quantitative out-
comes and contribute to the refinement of intervention
content, processes and definitive trial procedures—doing
so in a manner that was both rigorous and acceptable to
primary care stakeholders and patients.
To gain insight into clinical and organisational culture
and context, we collected relevant information and
documentation as appropriate. Practice websites, Care
Quality Commission reports and local authority public
health Joint Strategic Needs Assessment reports were
reviewed to provide contextual information in relation
to practice size, services and local area demographic.
Diabetes- and diabetes education-related patient infor-
mation materials were also collated. Meeting notes and
task plans developed between the Embedder and prac-
tices or Educators were also reviewed and contributed to
the final analysis. Action planning and action planning
review documents were analysed to assess the develop-
ment of embedding activity, the delegation of roles and
responsibilities and outputs.
NPT informed data collection instruments [16].
Guides were designed to facilitate observations and
interview discussions. The observational guide aided our
understanding of the intervention implementation
process, and a schedule of topics for discussion (Add-
itional File 1) explored the variety of experiences of each
participant group in relation to intervention implemen-
tation, outcomes and barriers and enablers to adopting
the toolkit.
Observations were undertaken totalling approximately
25 h of practice and provider meetings and activities,
taking field notes in situ, which were then transcribed to
provide a full and rich account. Ethnography team de-
brief meetings were held to reflect on the observations
and interviews and identify salient points for future ex-
ploration in interviews. Tensions, inconsistencies, or am-
biguities in the data were also identified.
Individual and group interviews with stakeholders (pa-
tients, practice staff and SSME providers) were held and the
Embedder was interviewed at three-month intervals to ex-
plore perceptions of the implementation process, including
delivery and use of the toolkit and outcomes. All interviews
were audio-recorded with participant consent and tran-
scribed verbatim. Demographic data on participant charac-
teristics were collected using a brief questionnaire.
Cost data collection
A questionnaire and face-to-face interview were used to
obtain data on the cost of all the embedding activity
from the practice manager and an appropriate member
of staff in the CCG. A simple tick box tracker covered
the type of embedding activity implemented, the dur-
ation over which it was applied and whether it was still
ongoing. This tracker was completed by the practice and
the ‘Embedder’. This provided a census of what activities
were attempted as well as providing a measure of re-
source use in terms of time spent by the Embedder and
staff from each provider and practice, against which unit
costs could be applied. The unit cost was generated by
the practice manager interviews which asked for details
of staff time, consumables and other costs that have
been devoted to each individual activity over the dur-
ation that the activity was undertaken. The resource use
data for developing the web-based toolkit (a key compo-
nent of the Embedding Package) were obtained from the
designer.
Analysis
Statistical analysis
Quantitative data The data were analysed using de-
scriptive summary statistics to assess data completeness
and accuracy using mean, standard deviation (SD) and
range for continuous, normally distributed variables, me-
dian, interquartile range and range for continuous, non-
normally distributed variables and number (percentage)
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for categorical variables. Extracted primary care data
were summarised overall, by CCG and by practice to
identify whether there were CCG or practice-level varia-
tions in recording. Data from the questionnaire were
summarised using the same descriptive statistics. For the
participants who had consented to data linkage, their
questionnaire responses were linked to their practice
data using the pseudonymised NHS number. Where the
same categorical measure was available for both the
questionnaire and primary care data, these were cross-
tabulated and the percentage agreement, calculated. In
this comparison, missing values were ignored. For con-
tinuous variables, mean difference and limits of agree-
ment were calculated. All analyses were performed in
Stata 14.1.
For the practice activity tracker, a cross-tabulation of
activity by practice was undertaken, together with the
calculation of the mean duration of each activity across
practices. For the practice manager interviews, central
estimates of resource use for each activity are reported,
together with upper and lower bounds where there was
uncertainty relating to the best estimate. Estimates of re-
source use for each activity in each practice were multi-
plied by relevant unit costs and used to produce an
average cost per activity over time; this was then divided
by the number of patients with T2DM at the practice to
get a per-patient cost. Resource use data were valued by
applying unit costs using the University of Kent’s Per-
sonal Social Services Research Unit (PSSRU) unit costs
2016 and other sources where relevant (Additional File
2) [22, 23].
Qualitative data analysis
A thematic framework approach to the analysis of the
complete data corpus was adopted, to enable compari-
son within and between cases [24]. Management of data
were undertaken in NVivo. Analysis followed the pro-
cedure described by Gale and colleagues [24]:
I. Familiarisation with the transcript data: This stage
involved the reading, re-reading and open coding of
interview and debrief transcripts, supplemented by
the additional documentation to become familiar
with the data. Additionally, notes were made on the
transcripts to reflect any first impressions or
thoughts.
II. Coding: Open (inductive) coding was conducted
independently by two researchers and aimed to
classify all of the data; preliminary themes were
then organised and charted to identify accounts
that differed from the rest, or that which challenged
or reconciled anomalies in accounts.
III. Development of an analytical framework: After
coding and organising the data, initial themes were
organised by the four domains of NPT. Different
approaches to grouping and defining different
stakeholder data were considered.
IV. Application of the analytical framework: Using the
descriptors of the NPT domains [16] as guidance,
narrative data summaries were produced that
incorporated narrative and documentary data. After
making several attempts to logically organise data,
data were categorised and presented according to
stakeholder category (patient, practice, provider and
the Embedder).
V. Data interpretation: Throughout the analysis
process, the entire ethnography team met in a
series of analysis meetings to review findings and
procedures. These discussions formed the basis of
an agreed coding framework and where there was
uncertainty or disagreements concerning coding,
these were resolved through further discussion and
consensus between the research team.
Results
Assessment of the feasibility of two recruitment and
consent approaches
Two CCGs were approached; four expressions of inter-
est were received from one CCG and six from the other.
Six of these practices were then selected to participate in
the study and agreed to the extraction of their primary
care data. Eligible patients were then approached to par-
ticipate in the questionnaire, either by GP prompt or
postal invite. After the removal of duplicates, 423 unique
questionnaires (response rate 14.7%) were received
across the six practices (66 patients per practice on aver-
age; range = 8 to 102). Twenty eight patients did not
have a practice recorded (i.e. they returned the question-
naire anonymously). More participants were recruited
via the postal invite (85%) than the GP prompt (15%).
Of those returning a questionnaire, 384 (90.8%) con-
sented to have their questionnaire responses and pri-
mary care data linked. Of these, 20 (5.2%) could not be
linked because they did not provide their NHS number
and eight (2.1%) because they did not have their primary
care record extracted (three of these were recruited via
their GP and five via postal invitation).
Assessment of the feasibility of extracting demographic
and biomedical data, and information on SSME referral
and attendance from primary care medical records
Primary care data were extracted for all six practices and
for 2877 patients [mean = 479.5 patients per practice
(SD = 262.3); median = 459 (range = 118 to 824)]. All pa-
tients had a T2DM code and were aged 18 years or older
as required, but it was not possible to verify the other
eligibility criteria from the extracted data. The extracted
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data are summarised overall and by CCG in Tables 1
and 2 and by practice in Additional File 3.
Regarding SSME referral data, 63% of patients had no
record of ever being referred to an SSME programme,
20% had been referred to DESMOND, and 16% did not
have a specific type of course entered (i.e. the generic
SSME Read code had been used which is the recom-
mended code). The majority of patients’ last referral had
been over a year previously. There were 18 spurious re-
ferrals to SSME where the patients were referred to
DAFNE, which is a course for patients with type 1 dia-
betes, not T2DM.
Regarding SSME attendance data, 46% of patients were
not recorded as being referred to SSME. This is lower
than the 63% estimate based on the referral data. The dis-
crepancy arises because where patients were recorded as
attending or declining SSME, it was assumed that they
had been referred to SSME (n = 492 patients). Only 14%
of patients were recorded as having attended SSME, 26%
did not attend, and 14% were referred but had no GP rec-
ord as to whether or not they subsequently attended.
CCG 1 had more referrals recorded than CCG 2 (47%
vs 31%, respectively) but lower attendance recorded (ab-
solute values: 6% vs 19%, respectively, indicating that
13% of referrals in CCG1 resulted in attendance com-
pared with 60% in CCG 2). This difference may be as a
result of differing “quality” of the offer of SSME.
Accuracy of variables
Regarding accuracy of these variables, mean and SD esti-
mates were similar for all continuous variables when
summarised overall, by CCG and by practice, suggesting
that there were no consistent reporting errors in any of
the practices or CCGs. The only exception to this was
mean QRisk score which ranged from 17.4% to 28.3%
between the six practices. On the range checks, the only
spurious values identified were for weight which had
two likely outliers (< 0.001% of values) of 1.5 kg and 8.8
kg.
Missing data
Regarding completeness of demographic and biomedical
data, age, sex and smoking status had no missing values.
HbA1c and blood pressure had less than 10% missing
data, but there were more missing data for total (12%)
and HDL (17%) cholesterol, ethnicity (17%), weight
(22%) and QRisk score (51%). BMI and hospital admis-
sions were missing for all patients.
There were some fairly large differences in the per-
centages of missing data between CCGs. For example,
weight was missing for 9% of patients in CCG 1 and for
29% in CCG 2. Similarly, cholesterol was missing for a
higher percentage of patients in CCG 2 than in CCG 1,
whereas the higher percentage of missing QRisk scores
was in CCG 1. Examining the summary by practice sug-
gests that these differences are driven by one or two
practices with particularly high percentages of missing
values. For example, Practice 3 had only 24% missing
QRisk scores, whereas Practice 2 had 71% missing QRisk
scores.
Assessment of patient willingness to provide consent and
complete the questionnaire
The questionnaire had a 14.7% response rate across the
six practices, receiving 423 unique responses, which are
summarised in Table 3. An average of 66 patients per
practice (range 8 to 102) completed the questionnaire.
Demographics
The questionnaire participants were representative of
the eligible population (i.e. those for whom primary care
data were extracted) in terms of mean age [68 (SD =
Table 1 Summary of extracted continuous primary care data overall and by CCG
All (N = 2877) CCG 1 (N = 1036) CCG 2 (N = 1841)
Variable N (%)
missing
Mean
(SD)
Median (range) N (%)
missing
Mean
(SD)
N (%)
missing
Mean
(SD)
Age, years 0 (0) 66.0 (13.3) 67 (23, 101) 0 (0) 68.6 (12.5) 0 (0) 64.6 (13.5)
HbA1c, mmol/mol 189 (7) 56.1 (15.5) 52 (29, 179) 22 (2) 55.0 (13.4) 167 (9) 56.8 (16.6)
HbA1c, % 189 (7) 7.3 (1.4) 6.9 (4.8, 18.5) 22 (2) 7.2 (1.2) 167 (9) 7.3 (1.5)
Weight, kg 622 (22) 88.1 (21.9) 85.7 (1.5*, 215.0) 89 (9) 85.9 (20.4) 533 (29) 89.7 (22.8)
Total cholesterol, mmol/L 349 (12) 4.3 (1.1) 4.2 (1.9, 13.4) 67 (6) 4.3 (1.1) 282 (15) 4.3 (1.1)
HDL cholesterol, mmol/L 487 (17) 1.3 (0.4) 1.2 (0.2, 4.4) 73 (7) 1.3 (0.3) 414 (22) 1.3 (0.4)
Systolic blood pressure, mmHg 204 (7) 132.5 (13.7) 132 (86, 240) 41 (4) 133.7 (13.8) 163 (9) 131.8 (13.6)
Diastolic blood pressure, mmHg 204 (7) 75.1 (9.5) 76 (45, 134) 41 (4) 75.2 (9.6) 163 (9) 75.1 (9.4)
QRisk score, % 1468 (51) 23.1 (15.4) 19.9 (0, 98.7) 669 (65) 25.4 (15.4) 799 (43) 22.3 (15.3)
HDL high-density lipoproteins, CCG clinical commissioning group, SD standard deviation
*Removing outliers minimum weight was 39.7 kg
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Table 2 Summary of extracted categorical primary care data overall and by CCG
Variable N (%)
All (N = 2877) CCG 1 (N = 1036) CCG 2 (N = 1841)
Sex
Male 1588 (55.2) 575 (55.5) 1013 (55.0)
Female 1289 (44.8) 461 (44.5) 828 (45.0)
Ethnicity
White European 1948 (67.7) 618 (59.7) 1330 (72.2)
South Asian 219 (7.6) 56 (5.4) 163 (8.9)
Black 57 (2.0) 5 (0.5) 52 (2.8)
Other 32 (1.1) 12 (1.2) 20 (1.1)
Not otherwise stated 121 (4.2) 102 (9.9) 19 (1.0)
Missing 500 (17.4) 243 (23.5) 257 (14.0)
Smoking status
Never smoker 1425 (49.5) 508 (49.0) 917 (49.8)
Ex-smoker 1102 (38.3) 435 (42.0) 667 (36.2)
Current smoker 350 (12.2) 93 (9.0) 257 (14.0)
HbA1c, mmol/mol (%)
≤ 53 (≤ 7%) 1465 (50.9) 585 (56.5) 880 (47.8)
54–58 (7.1–7.5%) 385 (13.4) 148 (14.3) 237 (12.9)
59–64 (7.6–8.0%) 279 (9.7) 100 (9.7) 179 (9.7)
65–69 (8.1–8.5%) 152 (5.3) 58 (5.6) 94 (5.1)
70–86 (8.6–10.0%) 266 (9.3) 83 (8.0) 183 (9.9)
≥ 87 (≥ 10.1%) 141 (4.9) 40 (3.9) 101 (5.5)
Missing 189 (6.6) 22 (2.1) 167 (9.1)
Diabetes medication in the last 12 months
None recorded 639 (22.2) 215 (20.8) 424 (23.0)
DPP-IV 101 (3.5) 22 (2.1) 79 (4.3)
GLP-I 20 (0.7) 10 (1.0) 10 (0.5)
Insulin 263 (9.1) 80 (7.7) 183 (9.9)
Metformin 1425 (49.5) 559 (54.0) 866 (47.0)
SGLT-2 21 (0.7) 5 (0.5) 16 (0.9)
Sulphonylurea 346 (12.0) 136 (13.1) 210 (11.4)
Multiple diabetes medications 38 (1.3) 0 (0.0) 38 (2.1)
Other 24 (0.8) 9 (0.9) 15 (0.8)
Previous atrial fibrillation diagnosis
Yes 246 (8.6) 106 (10.2) 140 (7.6)
No 2631 (91.5) 930 (89.8) 1701 (92.4)
SSME referral
No record 1809 (62.9) 546 (52.7) 1263 (68.6)
DESMOND 586 (20.4) 106 (10.2) 480 (26.1)
X-PERT 2 (0.1) 0 (0.0) 2 (0.1)
DAFNE 18 (0.6) 2 (0.2) 16 (0.9)
Generic SSME code 462 (16.1) 382 (36.9) 80 (4.4)
Date of SSME referral
≤ 1 year 270 (9.4) 138 (13.3) 132 (7.2)
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11.1) and 66 (SD = 13.3) years, respectively) and sex dis-
tribution (58% and 55% male, respectively). White par-
ticipants were however over-represented in the
questionnaire population compared to those for whom
primary care data were extracted (91% and 68%, respect-
ively). Over half (52%) of the questionnaire participants
had long-standing T2DM (> 10 years). Time since diag-
nosis was not available in the primary care data for
comparison.
Management of diabetes
For HbA1c, the percentage reporting that they had had
it measured in the last 12 months (93%) was the same as
in the primary care data (93%). Self-reported HbA1c was
missing for 42% of participants. However, when missing
data were excluded, the percentages of patients with
HbA1c ≤ 53mmol/mol were very similar in the self-
report (56%) and primary care (55%) data, suggesting
that self-reported HbA1c data were incomplete but
accurate.
Another notable difference between the primary care
and self-report data is that 29% self-reported being pre-
scribed with multiple diabetes medications, whereas only
2% were recorded as such in the primary care data. Met-
formin was the most common medication (47% primary
care and 34% self-reported). A similar proportion re-
ported not being on any medication in the primary care
and self-reported data (23% and 22.9% respectively).
Referrals and attendance at SSME
Regarding SSME, 37% of patients reported never having
been referred compared with 63% in the extracted pri-
mary care data. The percentage who self-reported
attendance at group SSME (45%) was much higher than
that recorded in the extracted primary care data (14%).
In relation to the question, ‘Have you ever attended a
one-to-one session with an educator to teach you about
your diabetes (this would be outside of the normal care
you receive at your GP practice)?’, 17 of the 21 partici-
pants who responded positively reported that this had
happened as part of their normal care at their practice,
and so had incorrectly answered the question. Among
the eight participants who reported attending an online
SSME programme, four completed a Diabetes UK online
programme.
The majority of the participants (70%) reported that
they would attend SSME if invited. The preferred
formats were one-to-one (29%) or group (24%). Fewer
participants preferred a format including an online com-
ponent (online, group/online or one-to-one/online; 19%)
than face-to-face only formats (group, one-to-one or
group/one-to-one; 62%).
Assessment of patient willingness to provide consent for
accessing and extracting identifiable data from their
medical records
In total, 356 participants were included in the linked
analyses, which are summarised in Table 4.
High levels of agreement were demonstrated for the
demographic variables: age (mean difference = 0.3 years),
sex (~ 100.0% agreement) and ethnicity (93% agree-
ment). The large discrepancy between multiple diabetes
medications described above is also present in the linked
data with 97% of those who self-reported taking multiple
diabetes medications having only one medication listed
in their extracted data over the previous 12months.
Table 2 Summary of extracted categorical primary care data overall and by CCG (Continued)
Variable N (%)
All (N = 2877) CCG 1 (N = 1036) CCG 2 (N = 1841)
> 1 year 798 (27.7) 352 (34.0) 446 (24.2)
Missing 1809 (62.9) 546 (52.7) 1263 (68.6)
SSME attendance
Not referred 1317 (45.8) 311 (30.0) 1006 (54.6)
Attendance not recorded 403 (14.0) 266 (25.7) 137 (7.4)
Did not attend 744 (25.9) 395 (38.1) 349 (19.0)
Attended 413 (14.4) 64 (6.2) 349 (19.0)
Date of SSME attendance
≤ 1 year 121 (4.2) 12 (1.2) 108 (5.9)
> 1 year 291 (10.1) 52 (5.0) 239 (13.0)
Missing 2465 (85.7) 972 (93.8) 1493 (81.1)
CCG clinical commissioning goup, SSME structured self-management education, DPP-IV dipeptidyl peptidase 4, GLP-I glucagon-like peptide-1, SGLT-2 sodium-
glucose transport protein 2
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Table 3 Summary of patient questionnaire data (n = 423)
Characteristic N missing values Mean (SD)
Age, years 6 68.3 (11.1)
Categories N (%)
Recruitment source General practitioner 64 (15.1)
Postal invite 359 (84.9)
Sex Male 243 (57.5)
Female 179 (42.3)
Missing 1 (0.2)
Ethnicity White 385 (91.0)
South Asian 21 (5.0)
Black 8 (1.9)
Other 6 (1.4)
Missing 3 (0.7)
Time since type 2
diabetes diagnosis
< 12 months 19 (4.5)
1 to 3 years 29 (6.9)
4 to 10 years 146 (34.5)
> 10 years 220 (52.0)
Missing 9 (2.1)
HbA1c measured in the
last 12 months
Yes 392 (92.7)
No 13 (3.1)
Do not know 16 (3.8)
Missing 2 (0.5)
HbA1c result, mmol/mol ≤ 53 (≤ 7%) 136 (32.2)
54–69 (7.1–8.5%) 82 (19.4)
70–86 (8.6–10.0%) 19 (4.5)
≥ 87 (≥ 10.1%) 8 (1.9)
Missing 178 (42.1)
Diabetes medication None
(diet and lifestyle)
97 (22.9)
DPP-IV 7 (1.7)
GLP-I 1 (0.2)
Insulin 24 (5.7)
Metformin 145 (34.3)
SGLT-2 1 (0.2)
Sulphonylurea 10 (2.4)
Multiple diabetes
medications
121 (28.6)
Other 0 (0.0)
Missing 17 (4.0)
Ever referred to SSME No 158 (37.4)
Yes 241 (57.0)
Do not know 14 (3.3)
Missing 10 (2.4)
Date of SSME referral ≤ 1 year 55 (13.0)
> 1 year 166 (39.2)
Table 3 Summary of patient questionnaire data (n = 423)
(Continued)
Do not know 5 (1.2)
Missing 197 (46.6)
Ever attended group SSME No 211 (49.9)
Yes 190 (44.9)
Missing 22 (5.2)
Type of SSME attended N/A 233 (55.1)
Unknown 20 (4.7)
DESMOND 72 (17.0)
Juggle 53 (12.5)
Tonic 1 (0.2)
Other 21 (5.0)
Missing 22 (5.2)
Date of SSME attendance ≤ 1 year 29 (6.9)
> 1 year 116 (27.4)
Missing 278 (65.7)
Re-invited if did not attend No 128 (30.3)
Yes 11 (2.6)
Missing 284 (67.1)
Reason for not attending
SSME
Lack of information 2 (0.5)
Lack of perceived benefit 16 (3.8)
Unsuitable time 5 (1.2)
Suitable transport
unavailable
3 (0.7)
Othera 33 (7.8)
Rather not say 1 (0.2)
Missing 363 (85.8)
Ever attended one-to-one
SSME
No 372 (87.9)
Yes 21 (5.0)
Do not know 15 (3.6)
Missing 15 (3.6)
Ever attended online SSME No 403 (95.3)
Yes 8 (1.9)
Do not know 2 (0.5)
Missing 10 (2.4)
Would you attend SSME
if invited?
No 99 (23.4)
Yes 299 (70.7)
Missing 25 (5.9)
Reason for not wanting
to attend if invited
Lack of information 1 (0.2)
Lack of perceived benefit 24 (5.7)
Unsuitable time 3 (0.7)
Suitable transport
unavailable
9 (2.1)
Otherb 44 (10.4)
Rather not say 1 (0.2)
Missing 341 (80.6)
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Management of diabetes
Most participants were aware whether they had had
HbA1c measured in the last 12 months (98% agreement),
but self-reporting of HbA1c values was fairly poor. For
example, the mean difference was small (− 0.6 mmol/
mol), but the 95% limits of agreement were large ranging
from − 13.1 mmol/mol (− 3.4%) to 12.0 mmol/mol
(3.2%). There seemed to be a particular problem with
participants reporting high HbA1c values (≥ 70mmol/
mol; 8.6%) that were not reflected in their primary care
record. This may be due to participants confusing glu-
cose measurements with measurements of HbA1c.
Referrals and attendance at SSME
For SSME referrals, agreement was moderate (60%).
Of those who self-reported that they had not been re-
ferred, 77% also had no record of referral in their pri-
mary care data. However, of those who self-reported
that they had been referred, only 54% had a record of
this in their primary care data suggesting that not all
of the discrepancy between the two sources is due to
the representativeness of the questionnaire partici-
pants. For SSME attendance, there was high agree-
ment between the two sources when the participant
self-reported that they had not attended (97%). How-
ever, when the participant reported that they had
attended SSME, there was only a primary care record
of this for 46% of the participants. Where both
sources had a record of referral and attendance, there
was high agreement as to when this had occurred
(87% and 86% respectively).
Feasibility of capturing cost data for Embedding activities
at practices and CCGs
Initiative tracker and proforma completion
Resource use and cost data were collected for all partici-
pating practices, CCGs and SSME providers based on
the Embedder’s tracker. Each of the pre-specified inter-
vention components (marketing, referral and data
collection, champion, administrator, and web-based tool-
kit) was attempted by at least one practice over the study
follow-up. However, none of the CCG designates and
practice managers completed the intervention tracker or
proforma.
Interviews
One GP practice agreed to take part in the face-to-face
interview with the Health Economist to discuss resource
use and costs incurred to allow the Embedding interven-
tion to take place. The interview was undertaken with the
Champion (a senior health care professional) and practice
administrator who were both involved in implementing
the feasibility study at practice level. Since no intervention
activity tracker or proforma was completed in advance of
the meeting, the interview was based on the information
from the Embedder’s tracker record for the practice (e.g.
staff time spent in providing each activity). The interview
provided the information required for estimating unit
costs for valuation of resource use at the practice level
(e.g. diabetes awareness event, providing resources in dif-
ferent languages to patients, photocopying).
Cost estimation
For the six practices, the median period over which re-
source use data was recorded was 162.5 days (range: 144
to 191). For CCG and SSME providers, the median
follow-up was 152 days (range: 150 to 154). The mean
total cost per practice over the study period was able to
be estimated as £3363 (SD = 2140), with an average cost
per patient of £8.94 across all practices. However, if the
cost for developing the Embedding Package toolkit is re-
moved from this calculation, the mean total cost per
practice is reduced. The Embedding intervention will be
tested across 66 general practices in the full RCT (sam-
ple size informed by the average practice size for this
feasibility study), and if shown to be effective, the toolkit
will be provided across the whole NHS [25]. Therefore,
it is felt the development cost per practice for this feasi-
bility study provides an unrealistic real-world cost per
practice.
The breakdown of costs for each individual activity by
CCG/SSME provider and practice and the mean cost
per patient (weighted by the number of patients with
T2DM in each CCG and practice) were also able to be
estimated.
Qualitative study findings
Feasibility of using ethnographic methods
It was concluded that the methods chosen to generate
and collect qualitative data kept the participant burden
low and would be feasible in a larger scale RCT. The fol-
lowing sub-sections describe the feasibility of collecting
documentary, observational and interview data.
Table 3 Summary of patient questionnaire data (n = 423)
(Continued)
Preferred format Group 103 (24.4)
One-to-one 122 (28.8)
Online 64 (15.1)
Group/one-to-one 39 (9.2)
Group/online 9 (2.1)
One-to-one/online 7 (1.7)
Any 12 (2.8)
Missing 67 (15.8)
SD standard deviation, SSME structured self-management education
aThese reasons are listed in Additional File 4
bThese reasons are listed in Additional File 5
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Feasibility of collection and review of documents
Both publicly available information and internal commu-
nications and documents arising from the intervention
delivery were collected. This included emails between
the Embedder and stakeholders about local information,
planning, refining and evaluating the impact of interven-
tion features; the development of promotional and pa-
tient information material; SSME attendance rates;
presentations given by the Embedder and providers;
meeting notes; and practice workflows. For some of
these, further explanation was sought during interviews
with the Embedder. These documents helped to
understand the wider context of practices, SSME pro-
viders and commissioners. Of note, documents revealed
the financial, workforce capacity and policy constraints
facing practices and providers, which impacted on their
ability to improve and innovate patient care.
Feasibility of collecting observational data
Over the course of the study, the two qualitative re-
searchers became familiar to practice staff and other
stakeholders from regular attendance at meetings and
events accompanying the Embedder. It was found to be
helpful to spend time engaging in informal conversations
Table 4 Agreement between primary care and patient questionnaire data (n = 356)
Characteristic N Mean difference 95% Limits of agreement
Age, years 352 0.32 − 2.17, 2.81
HbA1c, mmol/mol 40 − 0.66 − 11.33, 10.00
Characteristic Categories N (%) agree N (%) disagree % Agreement
Sex Male 212 (99.5) 1 (0.5)
Female 142 (100.0) 0 (0.0) 99.7
Ethnicity White 256 (93.8) 17 (6.2)
South Asian 13 (81.3) 3 (18.7)
Black 5 (83.3) 1 (16.7)
Other 1 (50.0) 1 (50.0) 92.6
HbA1c measured in the last 12 months Yes 323 (97.9) 7 (2.1)
No 9 (81.8) 2 (18.2) 94.7
HbA1c result, mmol/mol ≤ 53 (≤ 7%) 108 (93.1) 8 (6.9)
54–69 (7.1–8.5%) 43 (61.4) 27 (38.6)
70–86 (8.6–10.0%) 5 (33.3) 10 (66.7)
≥ 87 (≥ 10.1%) 2 (28.6) 5 (71.4) 76.0
Diabetes management Diet and lifestyle 71 (88.9) 9 (11.3)
DPP-IV 5 (71.4) 2 (28.6)
GLP-I 1 (100.0) 0 (0.0)
Insulin 15 (75.0) 5 (25.0)
Metformin 118 (96.7) 4 (3.3)
SGLT-2 1 (100.0) 0 (0.0)
Sulphonylurea 8 (100.0) 0 (0.0)
Multiple diabetes medications 3 (2.9) 101 (97.1)
Other 0 (0.0) 0 (0.0) 55.9
SSME referral No 101 (76.5) 31 (23.5)
Yes 111 (54.2) 94 (45.9) 59.6
Date of SSME referral ≤ 1 year 26 (76.5) 8 (23.5)
> 1 year 67 (91.8) 6 (8.2) 86.9
SSME attendance No 169 (96.6) 6 (3.4)
Yes 78 (46.4) 90 (54.6) 72.0
Date of SSME attendance ≤ 1 year 13 (100.0) 0 (0.0)
> 1 year 37 (82.2) 8 (17.8) 86.2
SSME structured self-management education
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with practice staff and observing workflows, use (or
non-use) of the intervention tools, as well as interaction
with the Embedder. These interactions, and researcher
interpretations of them, were documented in detailed
narrative field notes. Through more structured observa-
tions (for example, shadowing staff during a half-day pa-
tient engagement and screening event) further workflow
were able to be observed, featuring patient engagement
and the availability of education materials, as well as the
clinic environment. This approach helped to achieve the
goal of gaining a concrete understanding of how a prac-
tice works, in order to ground the analyses of the Em-
bedding Package’s adoption within the day-to-day work
of practice staff. Observation identified issues that could
be fed back to inform refinements to the Embedding
Package; for instance, a community engagement event
uncovered a previously unidentified potential for patient
stigmatisation and highlighted the need to consider the
acceptability of locations for public engagement.
Feasibility of recruiting to and undertaking individual and
group interviews
It was anticipated that it would be possible to arrange
face-to-face interviews with stakeholders during lunch
breaks or allotted Continuing Professional Development
(CPD) or administrative times. However, given constraints
on stakeholder availability, more success was had conduct-
ing these by telephone. It was helpful to start by briefly re-
capping their involvement in the study, which enabled us
to focus on the most relevant issues. The questions were
refined based on the content of the discussion. Once
agreeing to participate, no participant withdrew. However,
considerable efforts were made by the research team to re-
tain participants including flexibility in the timings, loca-
tions and methods of interviewing.
Patient interviews conducted over the telephone at a
pre-arranged time were logistically easy, but did not gen-
erate useful data, owing to the limited time since the
intervention had been implemented, resulting in little
impact and change to usual care being reported by pa-
tients. This has led to refinement of the plans for the
RCT; patients will be recruited and interviewed much
later in the implementation process, to allow for the
intervention to filter through to patient care.
Interviews with the Embedder transpired to be crucial
in facilitating understanding of the embedding process
and stakeholder engagement. It became apparent that
practice and provider stakeholders were excessively reli-
ant on the Embedder due to resource and capacity limi-
tations, and the need to facilitate low-resource, high-
impact strategies was identified. The Embedder’s insights
identified the need to build trust and enhance communi-
cation with stakeholders to develop their confidence in
making process changes; this directly informed the
methods and strategies for the RCT.
Evaluation of applying Normalisation Process Theory
Overall, NPT was useful in structuring the approach to
the ethnographic data collection and analysis. It was a
helpful device to sensitise and focus the researchers’
consideration on structural, individual and cognitive fac-
tors related to the implementation of the Embedding
Package, as well as to uncover challenges and enablers,
practical issues and the collection of data (Table 5).
Structuring the findings into the NPT domains enabled
pragmatic solutions and recommendations to be devel-
oped and fed back to the wider team and, in turn, in-
form the RCT design. However, it was not possible to
apply some of the findings to just one particular domain
construct and encountered a good deal of crossover be-
tween concepts, particularly within the domain of coher-
ence. To enhance the analysis for the RCT, some of the
constructs and domain descriptors have been modified
to fit the context.
Identifying and collecting contextual data on
implementation processes, sustainability of change and fit
of the intervention with routine practice
Data identified a number of contextual factors likely to
impact on the implementation, adoption and sustainabil-
ity of the intervention. Leadership, workforce focus and
motivation to change were the three main factors identi-
fied as impacting intervention implementation and
adoption. During the interviews and observations and
through document analysis, it became evident that prac-
tice leaders had to align innovation work with national
and local priorities and areas of focus. Example quota-
tions are referred to in text and are presented in Table 6.
In relation to leadership, practice managers and lead
clinicians regarded it as their responsibility to be both
familiar with and committed to the research agenda and
improving patient outcomes. Nothing explicit regarding
leadership and SSME for T2DM was identified through
document analysis of the practices strategy. However,
leadership was implicit when organisational issues were
described, both at a practice and provider level, as well
as wider levels of service commissioning (Table 6;
Quotation A).
The focus of the workforce, infrastructure and re-
source availability were contextual factors that emerged
during observations and interviews with practice stake-
holders. Challenges in relation to implementation and
integration were identified through observations and
document analysis and were directly related to the lack
of readiness, both in terms of research and the organisa-
tion, local infrastructure and limited guidance from
commissioners (Table 6; Quotation B).
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Motivation to change emerged from the interviews with
both practice and provider stakeholders, where partici-
pants talked about the potential benefits that could arise
from the intervention. Analysis of interviews revealed that
practice stakeholders were motivated to use the Embed-
ding Package to inform and refine their practice, if there
was a practical and observable benefit for it (Table 6;
Quotation C). However, unlike provider participants who
reported leadership support to refine existing practices
and procedures, practice stakeholders did not address
leadership as a focal point when describing how the pack-
age was integrated (Table 6; Quotation D). Leadership did,
however, emerge as a factor in observational data, but re-
lated to a lack of dissemination with respect to the adop-
tion of the intervention in certain practices.
Exploring methods to refine the intervention and study
procedures
As indicated, a key objective was to develop and opti-
mise methods for feeding back findings from the ethno-
graphic study to the wider team to inform the
refinement of the Embedding Package. Bi-monthly meet-
ings were held between two members of the ethno-
graphic team (LH and JT), the Embedder and the trial
manager to explore the findings, study challenges and
enablers, and any intervention content, potential issues,
or study procedures that required further exploration or
refinement.
Findings were shared with the feasibility study team
and trial management group on a monthly basis. In
brief, findings were structured into three categories (Fig.
2): (a) organisational factors that are specific to the local
setting (including support, leadership, culture, values
and resources); (b) intervention features that may influ-
ence implementation and adoption (e.g. documents,
clarity of aims/objectives, systems and procedures, team
capacity and feedback); and (c) characteristics of local
research teams (including staff roles, communication
and information sharing).
Health professionals believed the intervention in-
creased their awareness of SSME, which in turn meant
that greater encouragement and more options for acces-
sing SSME could be offered to patients newly diagnosed
with T2DM. Case examples demonstrating impact can
be found in Additional File 6.
Discussion
The feasibility of conducting a large-scale evaluation of
the Embedding Package in primary care was tested,
using a concurrent mixed methods approach. Although
no formal feasibility thresholds were set, which is a limi-
tation of this study, we have been able to demonstrate
the feasibility of a future RCT based on nine predefined
feasibility objectives. A summary of the findings of this
study, in relation to each of the feasibility objectives, is
provided in Additional File 7.
Data were successfully extracted from primary care
health records. Patients were willing to be recruited to
the study and to consent to their questionnaire data be-
ing linked to their extracted primary care data. It was
feasible to capture cost data for Embedding activities
and produce a cost estimate for each individual initiative
attempted as part of the Embedding Package. Stake-
holders from practices that engaged fully reported in-
creased understanding of the content of SSME, which
was used to inform the information delivered to patients
during consultations. However, there was limited en-
gagement from the majority of the participating prac-
tices. Focussing the intervention implementation on
practice staff, who are ultimately not responsible for de-
livering SSME, was not feasible given the capacity con-
straints in practices. The RCT will therefore focus
intervention implementation at the provider-level where
possible, whilst maintaining relationships with practices
and CCG personnel. This includes action planning
meetings taking place with local SSME providers and
then cascading the information down to practices when/
where appropriate.
Primary care data were extracted for all practices, but
from fewer patients than anticipated, as practice sizes
were lower than predicted. The proportion of patients
returning a completed questionnaire was higher than ex-
pected, and over 90% of these then consented to the
linking of their data. These recruitment figures will be
used to calculate the sample size for the RCT. Generally,
there was good completeness of the extracted data, par-
ticularly for HbA1c, the primary outcome for the RCT;
however, the same cannot be said for the self-reporting
of HbA1c. This was over 40% missing; although, where
it was reported, it was found to be accurate. This is in
line with the findings of research assessing the preva-
lence of HbA1c self-knowledge among T2DM patients
[26]. Due to the poor reporting of HbA1c in the ques-
tionnaire, this will be removed from the questionnaire
for the RCT.
Other changes will also be made to the questionnaire,
including the method of invitation, which will now be
solely via postal invite, due to the GP prompts yielding
fewer participants and being unpopular with the prac-
tices. Biomedical and SSME information and preferences
will also be removed from the questionnaire, to better
complement the data available from primary care and
other studies. Whether or not a participant has been re-
ferred to and attended SSME will still be collected, as
this has been shown to be a useful tool for validating
primary care records. However, there was only moderate
agreement between the questionnaire and primary care
records in terms of referral and attendance at SSME,
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suggesting that not all of the discrepancy between the
two sources is due to the representativeness of the ques-
tionnaire participants. This discrepancy may be due to
participants misunderstanding what was meant by
SSME; a clearer explanation of what SSME is will there-
fore be included. There is also the possibility that since
referral rates appeared to differ from national figures
[10], that some referrals may not have been recorded in
the primary care records or that the practices recruited
were not as representative as we hoped. The full RCT
will include a larger number of practices, so will be more
representative. Printed on each questionnaire booklet
will be a preassigned participant identification number
which can be linked to the individual’s NHS number;
this will reduce the quantity of missing NHS numbers
which prevented data linkage despite the participant
providing consent.
Although it was found to be feasible to collect data for
costing the Embedding Package initiatives in the full
RCT, it was not feasible to categorise initiative costs
based on ‘development’ and ‘steady’ state phases, as
these data were planned to be collected by a practice
and CCG proforma, but these were not completed. In-
stead, costs were estimated as an average cost per initia-
tive over the study period. Completing the initiative
tracker and proforma by the CCG designates and prac-
tice managers proved challenging and unfeasible. It is
anticipated that the majority of the work in the RCT will
occur at the ‘provider’ level, although most of this may
be down to the Embedder. Accordingly, the education
Table 5 Normalisation Process Theory constructs, domains and coding examples
Domain (Components) Description Example
Coherence
(differentiation, communal specification,
individual specification, internalisation)
The sense-making work that people undertake indi-
vidually and collectively
‘One of the practices responded to a very specific
question which was around me going and putting the
display board up for World Diabetes Day. But when
asked to review the Action Plan and things like that
have not had any response, and I have followed
things up two or three times’
(The Embedder).
Cognitive participation
(initiation, enrolment, legitimation,
activation)
The relational work undertaken by people to build
and sustain a community of practice around a new
intervention
‘No I didn’t use any [Embedding Package Resources]
because the doctors don’t actually do the direct
referral to [Structured Education] because it is an
administrative task’
(GP, Practice 5).
Collective action (interactional
workability, relational integration,
skillset workability, contextual
integration)
The operational work that people undertake to
enact a set of practices
‘We sourced a lot of brochures and leaflets from the
Diabetes websites and we made contact with a little
bit of help from [The Embedder] with the local
diabetes support group which has been fantastic
they’re really, really, useful’
(Practice Nurse, Practice 5).
Reflexive monitoring
(systemisation, communal appraisal,
individual appraisal, reconfiguration)
The appraisal work that people undertake to assess
and understand the ways that a new set of
practices affects them and others around them
‘In one of the pharmacies that we visited, there was
on particular gentleman that has, I don’t know a
couple of Pharmacies in the local area, and was really
enthusiastic about it, and was giving us feedback as
well about people using the Pharmacy, and has given
them feedback about [Structured Education] and it
was positive’
(Educator, Provider 2).
Table 6 Example quotations
A It has been massively beneficial from a personal point of view in terms of helping us get things [monitoring and referral strategies] in place that
will hopefully, help longer term. It’s also helped us as an organisation think about things that perhaps we’ve not considered before like working a
bit more up closely with Pharmacies and so forth. (Educator Lead)
B There is a read code that comes in so we can capture the people that have been [to SSME] but really what we want to capture more is the
people that have not… And not the ones who have cancelled their appointment, but the ones who didn’t bother to make one even in the first
place. (Practice Manager)
C I have seen plenty of patients walking out with them in various languages and I think sometimes, it is surprising that somebody might have had
diabetes for the last 10 years but never really had a good conversation about it. I have had at least one consultation where somebody had read
the leaflet and actually, it prompted him or her [patient] to re-engage. I have seen it as a positive thing. (Practice Nurse)
D We’ve never done anything for World Diabetes Day, Diabetes Awareness anything like that before. Obviously having done several diabetes trials
and working with [The Embedder] this year as well, we decided that we would promote it and try and raise awareness. (Practice Nurse)
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provider will be added as a key source for collecting re-
source use data and the role of the Embedder will be
maintained and strengthened in the full RCT. Both CCG
designates and practice managers will be removed as
sources for collecting resource use data because it has
proven unfeasible. Consequently, the resource use data
collection tools for the RCT will be amended to reflect
this change. Education providers will be supported to
ensure that all relevant resource use and cost data are
captured over the full RCT follow-up.
The qualitative work highlights that the success of the
intervention depends on the organisational context.
There were challenges directly related to a lack of readi-
ness, both in terms of research and the organisation,
local infrastructure and limited guidance from commis-
sioners. These various contextual factors need to be
addressed in the RCT in order to optimise the likelihood
for successful implementation and adoption. In order to
scale the Embedding Package across many organisations,
the work of the Embedder will be imperative to local en-
gagement with and adoption of the intervention. With
knowledge of the local context gained at the launch of
the intervention and continued contact and develop-
ment, implementation issues can be identified and miti-
gated. Furthermore, with the RCT planning to target
intervention implementation at the provider level where
possible, the challenges identified with practice engage-
ment with the Embedder will be overcome, since one or-
ganisation provides SSME for numerous practices [25].
Low levels of uptake and use may be explained in part
by a lack of organisational readiness at a local (practice)
level and different focus of various stakeholders; thus,
Fig. 2 Findings from the ethnographic study, grouped by organisational, intervention and team factors
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aligning interests across multiple stakeholders and orga-
nisations remains a challenge when planning an inter-
vention in primary care. Another challenge lies in the
implementation process and in the integration of SSME
in usual practice. For practices, there is uncertainty
about SSME in general, and concerted and ongoing ef-
forts will be required in the RCT to integrate referral
and engagement practices as a routine and sustained
part of primary care provision. Despite the challenges
that were present, a number of low-capacity high-return
activities were identified. These include patient informa-
tion leaflets tailored to the cultural and demographic
needs of the practice, promotional videos, waiting room
or reception area displays, self-referral forms, and en-
gagement with existing initiatives and partnership work-
ing. However, constraints on the timings of this
feasibility study meant that the Embedding Package was
not utilised sufficiently in practice to have impacted on
patient’s awareness and/or experience, particularly at the
time patients were recruited to participate in interviews.
Patient interviews will be conducted later in the RCT, to
allow time for the intervention to have filtered through
to patient care. NPT was found to be useful in structur-
ing our approach to ethnographic data collection and
analysis. However, it was difficult to apply some of the
findings to a single domain construct, and so, to enhance
the analysis in the RCT, some of the constructs and do-
main descriptors will be customised.
Conclusion
It is feasible to collect demographic, biomedical and
SSME referral and attendance data with reasonable com-
pleteness and accuracy for the subsequent RCT; how-
ever, measures can and will be taken to further improve
the quality of the data collected. Based on this feasibility
study, it is also feasible to collect data for costing the
Embedding Package initiatives for the full RCT; however,
changes are required to some elements of the resource
use data collection strategy. Based on data collected, it
was feasible to produce cost estimates for each individ-
ual initiative attempted as part of the Embedding Pack-
age. The methods chosen to generate, collect and
analyse qualitative data were satisfactory; they kept par-
ticipant burden low and provided insight into potential
refinements of the Embedding Package. Some further
development of the Embedding Package is required to
improve engagement from practices.
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